AMY GUAN: Open Payments
NPI 1801398813 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,126 in 129 payments from 20 companies in 2025. Trend: 2023 $475 · 2024 $2,271 · 2025 $2,126
Food & beverage: $2,126
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 21 | $329 |
| Novo Nordisk Inc | 15 | $269 |
| AstraZeneca Pharmaceuticals LP | 14 | $259 |
| Otsuka America Pharmaceutical, Inc. | 12 | $197 |
| ABBVIE INC. | 11 | $189 |
| Lundbeck LLC | 12 | $181 |
| Amgen Inc. | 9 | $144 |
| PFIZER INC. | 12 | $135 |
| Sumitomo Pharma America, Inc. | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $55 |
Products named: REXULTI, MOUNJARO, Ozempic, FARXIGA, Wegovy, UBRELVY, NURTEC ODT, EVENITY.
Industry payments across MO — which companies pay providers there.
